Man Group plc Increases Stock Position in Teleflex Incorporated (NYSE:TFX)

Man Group plc grew its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 296.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 127,256 shares of the medical technology company's stock after buying an additional 95,172 shares during the quarter. Man Group plc owned 0.27% of Teleflex worth $22,649,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. Headlands Technologies LLC bought a new stake in Teleflex in the fourth quarter valued at $29,000. Avior Wealth Management LLC grew its holdings in shares of Teleflex by 81.2% in the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after purchasing an additional 125 shares during the last quarter. IFP Advisors Inc grew its holdings in shares of Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock worth $55,000 after purchasing an additional 217 shares during the last quarter. Exchange Traded Concepts LLC lifted its holdings in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. Finally, R Squared Ltd bought a new position in Teleflex during the 4th quarter valued at about $64,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Teleflex Trading Down 2.2%

NYSE TFX traded down $2.83 on Wednesday, hitting $124.03. The company's stock had a trading volume of 60,709 shares, compared to its average volume of 634,638. The firm has a market cap of $5.48 billion, a PE ratio of 24.66, a PEG ratio of 1.73 and a beta of 1.17. The company's 50-day moving average is $132.50 and its 200 day moving average is $161.54. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 1-year low of $120.06 and a 1-year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. During the same period in the prior year, the firm posted $3.21 EPS. The company's quarterly revenue was down 5.0% on a year-over-year basis. As a group, analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's dividend payout ratio is currently 42.90%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Truist Financial dropped their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research note on Monday, May 5th. Citizens Jmp cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Piper Sandler reissued a "neutral" rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Finally, Raymond James cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.